BlackRock Fund Advisors - BIND THERAPEUTICS INC ownership

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of BIND THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$72,000
-10.0%
32,627
-7.2%
0.00%
Q4 2015$80,000
-47.0%
35,145
+3.8%
0.00%
Q3 2015$151,000
-4.4%
33,854
+20.0%
0.00%
Q2 2015$158,000
+50.5%
28,200
+48.1%
0.00%
Q1 2015$105,000
-4.5%
19,038
-6.4%
0.00%
Q4 2014$110,000
-15.4%
20,334
+34.8%
0.00%
Q3 2014$130,000
-39.0%
15,080
-6.7%
0.00%
Q2 2014$213,000
-88.3%
16,168
-89.4%
0.00%
-100.0%
Q1 2014$1,824,000
-14.3%
152,512
+8.1%
0.00%0.0%
Q4 2013$2,128,000141,0360.00%
Other shareholders
BIND THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 155,000$2,123,500,0001.67%
EMERALD MUTUAL FUND ADVISERS TRUST 604,207$8,426,0000.50%
BVF INC/IL 150,000$2,264,0000.40%
EMERALD ADVISERS, LLC 419,752$6,334,0000.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 256,384$3,869,0000.20%
Alyeska Investment Group, L.P. 62,087$937,0000.04%
THOMPSON DAVIS & CO., INC. 1,500$23,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 13,000$196,0000.03%
SSI INVESTMENT MANAGEMENT LLC 23,580$356,0000.03%
TFS CAPITAL LLC 20,933$316,0000.02%
View complete list of BIND THERAPEUTICS INC shareholders